Twist Bioscience Corporation (TWST) is currently Overvalued by 728.39%

Twist Bioscience Corporation (TWST) appears overvalued by approximately 728.39% based on our live valuation percent and intrinsic value estimate derived from DCF, P/E Multiple, and P/S Multiple models. Valuation can still differ across analyst models, growth expectations, and risk assumptions.

Downside (live) 728.39% (from live valuation API)
Confidence (live) 8.5/10 (High conviction overvalued)

Confidence Score is based on the magnitude of upside or downside vs intrinsic value.

Fair value estimate

Unlock fair value

Current price

$91.03

Stock valuation checker

Search our company database (same as the site header). Choose a result or type a ticker and press Check valuation.

Explore Our Valuation Calculators

Intrinsic Value Calculator (DCF)ROE Calculator Stock Valuation Calculator

Why is Twist Bioscience Corporation overvalued or undervalued?

Based on intrinsic value, Twist Bioscience Corporation (TWST) looks priced with a margin of safety relative to a cash-flow-based fair value that blends growth, reinvestment needs, and a risk-adjusted discount rate.

Compared to historical valuation, today’s multiple sits under the range implied by the company’s own five-year average—suggesting the market is more cautious than its own past pricing of similar fundamentals.

Market expectations embedded in the price imply a modest bar for execution: revenue cadence, margin stability, and capital returns would need to hold up to justify a sustained discount versus fair value.

Key metrics

P/E ratio: 8.2x
Revenue growth (TTM y/y): 21%
Profit margin: 35.2%
Fair value (model): Unlock

Next steps

Frequently asked questions — TWST

Is TWST overvalued right now?

Based on our 2026 models, Twist Bioscience Corporation (TWST) appears overvalued at $91.03 with roughly 728.4% downside versus fair value. Confirm with valuation ratios and financials before acting.

What is Twist Bioscience Corporation's intrinsic value?

Our DCF, P/E Multiple, and P/S Multiple models estimate whether TWST trades above or below fair value. At $91.03, Twist Bioscience Corporation currently looks overvalued on this snapshot. Tickerplace Pro unlocks the full dollar fair value estimate.

How is Twist Bioscience Corporation's intrinsic value calculated?

Tickerplace calculates TWST's fair value using Discounted Cash Flow (DCF), P/E Multiple, and P/S Multiple models. We compare the resulting intrinsic value estimate to the live market price to flag undervalued or overvalued positioning.

Is TWST undervalued right now?

A stock is undervalued when price sits below a supportable fair value range. Check whether TWST's gap aligns with fundamentals using the ratios and financial links on this page.

Peers for TWST: open their overvalued / undervalued view.

Instant valuation answer